.Merck defeats profits expectations, increases purchases expectation on tough demand for leading medicines like Keytruda CNBCMerck & Co. (MRK United States) Defeats Revenue Projections as Keytruda Purchases Rise BloombergMerck Inventory: Pharma Giant Posts Tough Results, But Overview Tumbles Short Investor's Company DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats profit and purchases assumptions amid Keytruda asset, but provides combined full-year expectation MarketWatch.